23/05/2022 - Events
Research and knowledge take to the streets again with the 15th Science Festival organized by the Barcelona City Council. Next May 28th and 29th 200 activities, 27 different spaces and more than 150 entities of the city related to science and outreach are waiting for you in the Rambla del Raval. In this sense, the Hospital del Mar Medical Research Institute (IMIM) invites you to the debate on "Animal Experimentation in Science" that organizes and that will take place on Saturday May 28 at 20:00h. The participants of the debate will be: Arnau Busquets: moderator and researcher with animal models at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar). Sergi Vila: member of the Agreement on transparency in animal experimentation COSCE (Confederation of Spanish Scientific Societies). Domingo Gargallo: co-founder and vice-president of REMA (Spanish Network for the Development of Alternative Methods in Animal Experimentation).
Més informació "Debate "Animal experimentation in science" - May 28th (15th Science Festival)"
18/05/2022 - Covid-19
A study by doctors and researchers at Hospital del Mar and the Hospital del Mar Medical Research Institute confirms that COVID-19 infection is much more virulent than the flu in this group of patients, despite the fact that they are younger and in better health. They also require longer hospital stays and more care. This means that the price of their treatment is double that of patients admitted for influenza, with an extra cost of almost 10,000 euros. The study has been published in the journal Clinical Infectious Diseases and presented at the European Congress of Microbiology and Infectious Diseases held in Lisbon.
13/05/2022 - General information
A platform developed by the Centre Nacional d'Anàlisi Genòmica (CNAG-CRG) allows doctors and researchers from Catalan hospitals to share data and otherwise scattered expertise and diagnose patients with neurologic rare diseases. During the pilot project, a diagnosis was provided to 67 out of 323 patients (20.7% of cases), just by reanalysing previously available data. The results constitute an important milestone for ending the 'diagnostic odyssey' faced by patients in Catalonia. The collaborative approach also resulted in the identification of six new genes linked to specific diseases, which will make it easier to diagnose certain diseases in the future. The results, published today in The Journal of Molecular Diagnostics, were possible thanks to the Undiagnosed Rare Disease Program of Catalonia (URD-Cat), funded by the Departament de Salut de la Generalitat de Catalunya. The URD-Cat project was coordinated by the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and involved more than 140 professionals from 15 different research centres and hospitals.
Més informació "Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients"
04/05/2022 - Press release
The Biomedical Informatics Research Programme of IMIM-Hospital del Mar has received one of the European Research Council (ERC) grants for the NovoGenePop project, the ERC Advanced Grant. Among the 253 researchers selected, only thirteen are from Spain. The project at the IMIM-Hospital del Mar, the only Spanish biomedical research centre to be selected, will develop bioinformatics tools to identify specific genes in certain individuals or populations. This may pave the way for accelerated research in fields such as cancer and hereditary diseases. In total, the ERC Advanced Grants have distributed 624 million between 253 European researchers. This is the fourth grant of this type that the IMIM-Hospital del Mar has received in the last years.
28/04/2022 - Press release
The study was carried out jointly by Germans Trias Hospital and the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar). The research team compared blood samples from 58 cases of patients hospitalised for heart attack complicated by primary ventricular fibrillation with those of 116 people who did not suffer this complication. A team of researchers from Germans Trias Hospital, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER on cardiovascular diseases has demonstrated that regular consumption of foods rich in linoleic acid can help to reduce the risk of cardiac arrest due to ventricular fibrillation during the acute phase of a heart attack. The results of the study have been published in the journal Scientific Reports.
21/04/2022 - General information
The research project PROMES-U has been launched with the goal of enhancing the mental health of university students through the exploration of factors influencing the onset of mental health issues. Additionally, the project aims to implement and evaluate online interventions for promoting mental well-being and preventing problems related to depression and anxiety. The study is led by the Hospital del Mar Medical Research Institute (IMIM) and involves participation from UPF, the University of the Balearic Islands, Jaume I University of Castellón, Miguel Hernández University of Elche, and the University of Zaragoza.
Més informació "PROMES-U Study Initiated to Promote Student Mental Health"
19/04/2022 - General information
The VALAWAI project, led by the CSIC with the participation of the Hospital del Mar Medical Research Institute and the Hospital del Mar, has received nearly four million euros from the European Innovation Council under the Pathfinder Challenges. A team from the Neuroimaging of Mental Disorders Research Group at the Hospital del Mar Medical Research Institute, led by Dr. Òscar Vilarroya, along with the Innovation Directorate of the Hospital del Mar, headed by Dr. Jordi Martínez, is part of the VALAWAI project (Value-Aware Artificial Intelligence). The project has recently been granted European funding of nearly four million euros. Its objective is to develop a set of tools for creating artificial intelligence systems that incorporate mechanisms sensitive to human values. In other words, these systems should be capable of deciding whether certain actions are morally acceptable and be aware of their users' value systems.
12/04/2022 - Press release
COVID-19 has accelerated the need to raise awareness of the psychological well-being of the human teams that form part of SME organisations, in the face of the economic uncertainty aggravated by the war in Ukraine.
31/03/2022 - General information
The project "Tumour microenvironment-derived factors in localised colon cancer: clinical impact and therapeutic implications' (TuMiCC)"aimed at demonstrating the value of the tumour microenvironment in predicting relapse in patients with localised colon cancer treated with adjuvant therapy, has reached the 16-month development milestone, with patient recruitment and interesting advances in the molecular characterisation of this type of tumour and its environment.
30/03/2022 - General information
A study by the Neuroimmunology Research Group at the Hospital del Mar Medical Research Institute (IMIM) has validated a possible marker that could improve the efficiency of one of the main multiple sclerosis treatments. The marker is a specific type of immune system cell, known as NK (Natural Killer) cells, which express a specific receptor on their surface, NKG2C. Currently, patients with multiple sclerosis are treated with anti-CD20 monoclonal antibodies, which are designed to eliminate the B-lymphocyte population in peripheral blood and thus control disease activity. These drugs are scheduled to be administered once every six months, although it is unclear whether this time period is appropriate for all patients. Several studies indicate that, depending on the drug given, it takes between six months and a year and a half for the levels of the B-lymphocyte population to recover.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact